|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jan 11, 2013 |
Title |
Dosage dependent tumor suppression by histone deacetylase 1 and 2 by regulation of Myc collaborating genes and p53 function |
Organism |
Mus musculus |
Experiment type |
Genome variation profiling by genome tiling array
|
Summary |
comparative genome hybridisation of Hdac1/2 cKO lymphomas and matched normal tissue Histone deacetylases (HDACs) are epigenetic erasers of lysine-acetyl marks. Inhibition of HDACs using small molecule inhibitors (HDACi) is a potential strategy in the treatment of various diseases and is approved for treating hematological malignancies. Harnessing the therapeutic potential of HDACi requires knowledge of HDAC-function in vivo. Here, we generated a thymocyte-specific gradient of HDAC-activity using compound conditional knockout mice for Hdac1 and Hdac2. Unexpectedly, gradual loss of HDAC-activity engendered a dosage dependent accumulation of immature thymocytes and correlated with the incidence and latency of monoclonal lymphoblastic thymic lymphomas. Strikingly, complete ablation of Hdac1 and Hdac2 abrogated lymphomagenesis due to a block in early thymic development. Genomic, biochemical and functional analyses of pre-leukemic thymocytes and tumors revealed a critical role for Hdac1/Hdac2-governed HDAC-activity in regulating a p53-dependent barrier to constrain Myc-overexpressing thymocytes from progressing into lymphomas by regulating Myc-collaborating genes. One Myc-collaborating and p53-suppressing gene, Jdp2, was derepressed in an Hdac1/2-dependent manner and critical for the survival of Jdp2-overexpressing lymphoma cells. Although reduced HDAC-activity facilitates oncogenic transformation in normal cells, resulting tumor cells remain highly dependent on HDAC-activity, indicating that a critical level of Hdac1 and Hdac2 governed HDAC-activity is required for tumor maintenance.
|
|
|
Overall design |
genomic DNA from LckCre+;Hdac1/2 cKO lymphomas and matched normal genomic DNA was hybridized onto a Nimblegen whole genome array
|
|
|
Contributor(s) |
Heideman MR, Wilting RH, Yanover E, Velds A, de Jong J, Kerkhoven RM, Jacobs H, Wessels LF, Dannenberg J |
Citation(s) |
23327920 |
|
Submission date |
Jan 10, 2013 |
Last update date |
Apr 05, 2013 |
Contact name |
Jan-Hermen Dannenberg |
E-mail(s) |
j.dannenberg@nki.nl
|
Organization name |
Antoni van Leeuwenhoek hospital
|
Street address |
Plesmanlaan 121
|
City |
Amsterdam |
State/province |
N-Holland |
ZIP/Postal code |
1066 CX |
Country |
Netherlands |
|
|
Platforms (1) |
GPL13924 |
Nimblegen 12-plex 135K full genome mouse custom NKI array [091016_MM9_RK_CGH_HX12] |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA185991 |
Supplementary file |
Size |
Download |
File type/resource |
GSE43407_RAW.tar |
74.5 Mb |
(http)(custom) |
TAR (of PAIR, TXT) |
Processed data included within Sample table |
Processed data provided as supplementary file |
|
|
|
|
|